跳到主要內容

Bradbury Daniel 的 Form 4 申報

Castle Biosciences Inc(CSTL),2023/3/6 申報

申報編號
0001447362-23-000046
申報時間
2023/3/6
交易日
2023/3/2-3/3
申報延遲
4 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 9 筆非衍生性交易。公開市場賣出合計 $59.9 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Bradbury DanielCIK 0001236397董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/3/2Common StockS賣出處分−4,559$23.16F2−$105,586.44179,980間接
2023/3/2Common StockS賣出處分−1,520$23.16F2−$35,203.291,260間接
2023/3/2Common StockS賣出處分−1,519$23.16F2−$35,180.0491,286間接
2023/3/2Common StockS賣出處分−2,250$23.58F6−$53,055177,730間接
2023/3/2Common StockS賣出處分−750$23.58F6−$17,68590,510間接
2023/3/2Common StockS賣出處分−751$23.58F6−$17,708.5890,535間接
2023/3/3Common StockS賣出處分−8,191$24.53F7−$200,925.23169,539間接
2023/3/3Common StockS賣出處分−2,730$24.53F7−$66,966.987,780間接
2023/3/3Common StockS賣出處分−2,730$24.53F7−$66,966.987,805間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $22.515 to $23.510, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

F6

This transaction was executed in multiple trades at prices ranging from $23.520 to $23.740, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

F7

This transaction was executed in multiple trades at prices ranging from $23.965 to $24.810, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)